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Background: α-oxoaldehydes are formed as toxic by-products during metabolic activity. The biologically most
important compound of this class, methylglyoxal, results from spontaneous phosphate elimination from
dihydroxyacetone phosphate and glyceraldehyde 3-phosphate which are intermediate glycolysis products.
Methylglyoxal-mediated modification of lipids, nucleic acids and proteins is known to lead to the formation of
advanced glycation end products. These modifications contribute to the aetiology of severe diseases like diabetes
and neurodegenerative disorders. By using simple model organisms it is possible to conveniently study the effects
of methylglyoxal on cellular processes. Here, results are presented on the effects of methylglyoxal on mycelium
growth, stationary phase entry (monitored by autophagy induction), mitochondrial morphology and protein
composition in the filamentous fungus Penicillium chrysogenum.
Results: Methylglyoxal leads to growth rate reduction of this fungus so that the entry into the stationary phase is
delayed. Mitochondrial morphology is not changed by methylglyoxal. However, rapamycin-mediated fragmentation
of mitochondria is prevented by methylglyoxal. Furthermore, three proteins are identified that are present in
lower abundance when methylglyoxal is added to the growth medium (aldo-keto reductase [Pc22g04850],
5-methyl-tetrahydropteroyl-triglutamate-homocysteine S-methyltransferase [Pc22g18630] and NAD-dependent
formate dehydrogenase [Pc12g04310]).
Conclusions: The presented results contribute to the understanding of cellular pathways and mechanisms that are
affected by the ubiquitous α-oxoaldehyde methylglyoxal.
Keywords: Autophagy, Green-fluorescent protein, Methylglyoxal, Mitochondria, Penicillium chrysogenum,
Peroxisomes, Stationary phaseBackground
Living cells depend on the enzymatic conversion of D-
glucose to pyruvate via glycolysis for the formation of the
molecular energy stores adenosine triphosphate (ATP)
and nicotinamide adenine dinucleotide (NADH). Glycoly-
sis, however, can also lead to the production of toxic by-
products. The best studied and probably the most relevant
compound of this class is the α-oxoaldehyde methyl-
glyoxal (also known as pyruvaldehyde or 2-oxopropanal)
[1]. Methylglyoxal is mainly formed by spontaneous elim-
ination of phosphate from the glycolysis intermediates di-
hydroxyacetone phosphate (DHAP) and, to a lesser extent,
glyceraldehyde 3-phosphate [2]. Another metabolic routeCorrespondence: Christian.Scheckhuber@senckenberg.de
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tion of aminoacetone in the catabolism of L-threonine
which is mediated by the semicarbazide-sensitive amine
oxidase [3]. Methylglyoxal can also be formed as a side-
product of lipid peroxidation under conditions of ele-
vated intracellular oxidative stress [4]. This α-oxoaldehyde
causes protein glycation and functional impairments due
to its high reactivity with amino groups of proteinaceous
lysine and arginine residues [5]. These residues are modi-
fied further and ultimately converted into ‘advanced glyca-
tion end-products’ (AGEs). For example, a major type of
AGE in cells of the human eye lens from aged donors is
the hydroimidazolone Nε-(5-hydro-5-methyl-4-imidazo-
lon-2-yl)-ornithine (MG-H1) [6]. Importantly, the MG-H1
modification is found to be also increased in pathological
conditions like Alzheimer’s disease, arthritis, diabetes,
renal failure and Parkinson’s disease [7]. Collagen type IVarticle distributed under the terms of the Creative Commons Attribution License
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baker’s yeast [11] have been identified as main targets of
methylglyoxal-mediated modifications. Collagen type IV
loses its ability to interact with integrins whereas the func-
tion of haemoglobin is compromised by an intensified
oxygen binding capacity. For yeast enolase 2 studies have
been performed in which in vivo and in vitro glycation
patterns after methylglyoxal treatment were compared. It
was revealed that in vivo glycation of enolase 2 is a specific
process where certain lysine and arginine amino acids are
consistently modified.
Unsurprisingly, cells possess protective mechanisms
that prevent or limit glycation damage. The best charac-
terised enzymatic system that detoxifies methylglyoxal
by conversion to D-lactate consists of three components:
glyoxalase I (GLO1, lactoylglutathione lyase), glyoxalase
II (GLO2, hydroxyacylglutathione hydrolase) and cata-
lytic amounts of reduced glutathione [12]. One example
demonstrating the importance of the glyoxalase system
for protecting organisms from the deleterious effects of
α-oxoaldehydes and subsequent glycation stems from
work on nematodes. Overexpression of the Glo1 gene in
Caenorhabditis elegans was found to increase the life-
span of this organism by protecting components of the
mitochondrial respiratory chain from glycation [13]. In
addition to glyoxalase I and glyoxalase II a novel type of
glyoxalase has been reported that is working independ-
ently of glutathione [14]. Mutant variants of this enzyme
(DJ-1/PARK7) have been reported to contribute to the
aetiology of autosomal recessive early-onset Parkinson-
ism [15]. Later studies revealed that some of these muta-
tions affect mitochondrial integrity in cellular models of
Parkinsonism [16, 17]. Recently, it was demonstrated that
D-lactate, which is also formed by DJ-1, is able to posi-
tively influence mitochondrial function by maintaining the
membrane potential of these organelles [18]. Collectively
these results demonstrate that not only the removal of
methylglyoxal but also an end-product of glyoxalase activ-
ity is important for maintaining cellular health and integ-
rity. Other enzymes that may limit the formation of
methylglyoxal are methylglyoxal reductase [19], aldo-keto
reductases [20], α-oxoaldehyde dehydrogenase and beta-
ine dehydrogenase [21] although their contribution to
methylglyoal degradation has been investigated less.
Recently the role of methylglyoxal and its degradation
by the glyoxalase system on fungal senescence was stud-
ied in the filamentous ascomycete Podospora anserina
[22]. It was shown that overexpression of genes encod-
ing glyoxalase I (PaGlo1) and glyoxalase II (PaGlo2) has
a beneficial effect on viability and delayed the onset of
senescence in this model system while the deletion of
PaGlo1 resulted in a strongly decreased lifespan com-
pared to the wild type when the strains were grown in
the presence of 2 % (w/v) glucose which is supposed toincrease the formation of methylglyoxal. These results
suggest a link between intracellular methylglyoxal levels
and fungal viability. Subsequently, the impact of in-
creased glyoxalase I and II levels was studied in an in-
dustrial producer of β-lactam antibiotics, Penicillium
chrysogenum [23]. Overexpression of PcGlo1 and PcGlo2
led to the improvement of penicillin (PEN) production
in this fungus. Analysis of protein levels revealed that in-
creased levels of two enzymes of the biosynthetic pathway
for PEN are present in the PcGlo1/PcGlo2 overexpression
strain. One of these enzymes, isopenicillin-N acyltransfer-
ase (IAT), is localised to peroxisomes [24], organelles of
anti-oxidative activity and sites of various pathways of sec-
ondary metabolism.
The aim of the present study was to elucidate the ef-
fects of exogenous methylglyoxal on mycelium growth,
initiation of the stationary phase, morphology of mito-
chondria and overall protein composition in P. chryso-
genum. It is revealed that methylglyoxal affects the
growth rate of the mycelium so that initiation of the sta-
tionary phase is delayed. Methylglyoxal has no effect on
mitochondrial morphology: thread-like mitochondria are
present in mycelia independent of methylglyoxal treat-
ment. By using differential isoelectric focusing (IEF)/two-
dimensional sodium dodecyl sulphate polyacrylamide
electrophoresis (2D-SDS-PAGE) in combination with pep-
tide mass fingerprinting three proteins that are present in
lower abundance compared to the control when methyl-
glyoxal is added to the growth medium are identified.
Results
Effects of methylglyoxal on mycelium growth
Although the consequences of overexpression of the
glyoxalase-encoding genes PcGlo1 and PcGlo2 for peni-
cillin production have recently been studied [23] the ef-
fects of exogenously added methylglyoxal on the growth
behaviour of P. chrysogenum have so far not been investi-
gated. The P. chrysogenum strain Ws54-1255 (GFP-SKL)
was grown on agarose pads without added nutrients,
‘starvation pads’ [25], in the presence or absence of ex-
ogenously added methylglyoxal and analysed by light mi-
croscopy (Fig. 1). A methylglyoxal concentration of 0.05 %
(v/v) was found to be suited for the studies because lower
concentrations (e. g., 0.005 % [v/v] and 0.01 % [v/v]) cause
no observable changes on the growth behaviour and
higher concentrations (e. g., 0.1 % [v/v]) led to almost
complete inhibition of growth. The untreated control
shows pronounced growth after 20 h and 40 h of incuba-
tion (Fig. 1a). At 60 h roughly the same amount of myce-
lium is present compared to 40 h which is an indication
for a stop of cell growth. This is probably based on nutrient
limitation encountered by the mycelium after prolonged
growth on the starvation pads. The samples subjected to
0.05 % (v/v) methylglyoxal grow initially (20 h) much
Fig. 1 Effects of methylglyoxal and rapamycin on growth of P. chrysogenum Ws54-1255 (GFP-SKL). At the indicated times pictures from cultures
grown on starvation pads were taken at the indicated time points. Representative images are shown for each time point. a control; b + 0.05 %
(v/v) methylglyoxal; c + 1 μM rapamycin; d + 0.05 % (v/v) methylglyoxal/+ 1 μM rapamycin. Scale bars: 100 μm
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tardation of growth demonstrates that methylglyoxal can
enter the fungal cells and interfere with their function. At
later time points (40 h and 60 h) the colonies are still
growing although their morphology looks quite irregular
(Fig. 1b). In samples treated with 1 μM rapamycin for
maximum induction of autophagy mycelium growth stalls
(similar to the untreated control) at 40 h (Fig. 1c). Rapamy-
cin is a well-known inhibitor of TOR (‘target of rapamycin’)
signalling [26]. This treatment leads to pronounced in-
duction of autophagy in most organisms [27]. When
rapamycin and methylglyoxal are added in combination
mycelium growth at all time points is reduced even
further compared to samples subjected solely to methyl-
glyoxal (Fig. 1d). Therefore rapamycin treatment seems
to sensitize P. chrysogenum towards exogenously added
methylglyoxal.
The observed differences in mycelium growth in the
presence or absence of methylglyoxal could be accompan-
ied by a delayed entry into stationary phase. In filamentous
fungi, autophagy induction is a marker for stationary phase
entry. Therefore degradation of GFP-SKL labelled peroxi-
somes as an autophagy marker was analysed by fluores-
cence microscopy (Fig. 2, Table 1). The utilised assay
is based on the principle that GFP is not efficientlydegraded by proteases localized in vacuoles [28]. There-
fore the presence of GFP in vacuoles is a measure for
peroxisomal degradation in the Ws54-1255 (GFP-SKL)
reporter strain. In untreated samples vacuoles filled with
GFP become visible after 40 h of incubation and these
are also present after 60 h (Fig. 2a). At the later time
point GFP localized to the vacuole lumen is observed in
ca. 50 % of hyphae (Table 1). By contrast, in samples
subjected to 0.05 % (v/v) methylglyoxal no GFP-labelled
vacuoles are observed up to 40 h (Fig. 2b, Table 1) in-
dicating that these mycelia have not entered stationary
phase by this time point. At a later time point (60 h)
GFP-labelled vacuoles become visible (Fig. 2b) but only
in approximately 25 % of hyphae (Table 1). After 40 h
pronounced vacuolation of hyphae is observed when
1 μM rapamycin was added to the samples (Fig. 2c,
Table 1). These vacuoles contain GFP suggesting peroxi-
somal degradation by autophagy (pexophagy). At 60 h
almost all hyphae contain GFP-labelled vacuoles (Table 1)
which are differing in morphology from vacuoles ob-
served at 40 h (their structure seems less regular and
they are filled with granulate matter which might be due
to the high level of degradation occurring in strains that
are subjected to both starvation and rapamycin). When
rapamycin and methylglyoxal are synergistically applied
Fig. 2 Localisation of GFP-SKL in Ws54-1255 (GFP-SKL) treated with
methylglyoxal and/or rapamycin. At the indicated times cultures grown
on starvation pads supplemented with or without methylglyoxal and/
or rapamycin were analysed using fluorescence microscopy.
Representative images are shown for each time point. a control; b +
0.05 % (v/v) methylglyoxal; c + 1 μM rapamycin; d + 0.05 % (v/v)
methylglyoxal/+ 1 μM rapamycin. Corresponding bright field areas are
shown below each fluorescence channel image. White arrows: GFP-
SKL localised to vacuoles. Scale bars: 10 μm
Table 1 Analysis of autophagy in control (Ws54-1255 (GFP-SKL))
and Δatg1 (GFP-SKL) strains
20 h 40 h 60 h
Control - + ++
+ MG - - +
+ R - ++ +++
+ MG/+ R - (+) +
Δatg1 - - -
+ MG - - -
+ R - - -
+ MG/+ R - - -
For each data point around 100 hyphae were analysed by fluorescence
microscopy. -: no peroxisome degradation observed, (+): weak peroxisome
degradation (5–10 % of all hyphae), +: ca. 25 % of hyphae display peroxisome
degradation, ++: ca. 50 % of hyphae display peroxisome degradation, +++:
90–100 % of hyphae display peroxisome degradation.MG methylglyoxal
(0.05 % [v/v]). R rapamycin (1 μM)
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there is no apparent difference to the untreated control
and exclusive methylglyoxal treatment, (ii) at 40 h a low
level of peroxisome degradation is detected which is not
seen in hyphae treated solely with methylglyoxal and (iii)
at 60 h the tendency of GFP to localise to vacuoles is
similar to samples treated with methylglyoxal alone. The
phenotype at 40 h indicates that methylglyoxal cannot
halt the induction of peroxisome degradation by rapamycin
treatment.
As negative control for autophagy induction the Δatg1
(GFP-SKL) strain was utilized (Fig. 3) which is defective
in both bulk (unselective) and selective autophagy [29].
This strain never shows a vacuolar localisation of GFP
regardless whether there is methylglyoxal present in the
growth medium or not (Fig. 3, Table 1). There are more
peroxisomes present in Δatg1 (GFP-SKL) compared to
Ws54-1255 (GFP-SKL), an effect that has been previously
reported [29]. These findings suggest that GFP-SKL is
not transported to vacuoles by autophagy-independent
processes.
Collectively the presented data suggest that methyl-
glyoxal affects mycelium growth by delaying the entry
into stationary phase.
Effects of methylglyoxal on mitochondrial morphology
Mitochondria display a strikingly dynamic morphology,
ranging from small punctuate units to long thread-like
structures. Their function depends on their morphology
among other factors. ‘Healthy’ mitochondria, capable of
synthesizing sufficient amounts of ATP, usually belong
to the filamentous morphotype whereas spherical mito-
chondria are often an indication for cellular stress and
death. It has been shown that mitochondrial morphology
Fig. 3 Localisation of GFP-SKL in P. chrysogenum Δatg1 (GFP-SKL)
treated with methylglyoxal and/or rapamycin. At the indicated times
cultures grown on starvation pads were analysed using fluorescence
microscopy. Representative images are shown for each time point.
Corresponding bright field areas are shown below each fluorescence
channel image. + MG: 0.05 % (v/v); + R: 1 μM rapamycin. Scale
bars: 10 μm
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to address the question whether methylglyoxal and/or
rapamycin affect viability of Ws54-1255 mitochondrial
morphotypes were determined (Fig. 4, Table 2). Control
cultures displayed a filamentous mitochondrial morph-
ology up to 60 h of growth on the starvation pad,indicating that Ws54-1255 is capable to tolerate this pro-
nounced starvation without the induction of cell death
(Fig. 4a; Table 2). Cultures growing in the presence of
0.05 % methylglyoxal exhibit a similar behaviour (Fig. 4b;
Table 2). However, when cultures were subjected to 1 μM
rapamycin, hyphae contained mostly round/spherical
mitochondria after 40 and 60 h of cultivation (Fig. 4c;
Table 2). Although not demonstrated experimentally, it is
suggested that this phenotype might be due to the induc-
tion of autophagy (mitophagy) as it is known that mito-
phagy is correlated with mitochondrial fragmentation [32].
Interestingly, when both methylglyoxal and rapamycin are
applied, mitochondrial morphology is mostly filamentous
after 40 h of incubation (Fig. 4d; Table 2). This finding sug-
gests that methylglyoxal is able to counteract rapamycin-
mediated fragmentation of mitochondria. However, after
60 h of incubation hyphae contain mostly round (frag-
mented) mitochondria (Fig. 4d; Table 2).
Response of P. chrysogenum to methylglyoxal at the
protein level
Methylglyoxal is known for its property to modify pro-
teins. It is also known that some proteins are more
susceptible for methylglyoxal-mediated glycation than
others [5]. The aim of this part of the study was not to
detect methylglyoxal-modified proteins but to elucidate
the response of P. chrysogenum to methylglyoxal present
in the growth medium (YGG + 0.2 % [v/v] methyl-
glyoxal). In this complete growth medium as opposed to
growth on starvation pads (see above) P. chrysogenum
was found to tolerate much higher methylglyoxal levels.
After cultivation protein extracts from the untreated
control and the methylglyoxal-treated sample were pre-
pared and separated using isoelectric focusing and two-
dimensional SDS-PAGE. Staining with a highly sensitive
Coomassie Blue variant revealed the separated proteins
which were in the size range of 3–30 kDa (Fig. 5). A ref-
erence protein (Fig. 5, R) was selected that is present (i)
in relatively high abundance, (ii) sufficiently isolated
from other proteins to facilitate its punching out from
the gel for characterisation and (iii) displays approxi-
mately the same staining intensity in the two gels (con-
trol and methylglyoxal). Three spots that are both
isolated from other proteins to minimize the risk of am-
biguous identification and present in higher abundance
in the control gel compared to the gel containing the sep-
arated proteins from the methylglyoxal-treated culture
were selected and punched out. Peptide mass fingerprint-
ing revealed the identity of these proteins as follows: Ref-
erence protein - peptide from the 60S ribosomal protein
L5 (systematic identifier: Pc13g11570); #1 - peptide from
aldo-keto reductase (Pc22g04850, EC 1.1.1.2); #2 - peptide
from 5-methyl-tetrahydropteroyl-triglutamate-homocyst-
eine S-methyltransferase (Pc22g18630, EC 2.1.1.14) and
Fig. 4 Analysis of mitochondrial morphology in Ws54-1255 treated
with methylglyoxal and/or rapamycin. At the indicated times
cultures grown on starvation pads supplemented with or without
methylglyoxal and/or rapamycin were overlaid with a Mitotracker
Green FM solution and analysed using fluorescence microscopy.
Representative images are shown for each time point. a control; b +
0.05 % (v/v) methylglyoxal; c + 1 μM rapamycin; d + 0.05 % (v/v)
methylglyoxal/+ 1 μM rapamycin. Corresponding bright field areas are
shown below each fluorescence channel image. Scale bars: 10 μm
Table 2 Mitochondrial morphotypes in Ws54-1255
20 h 40 h 60 h
Control fil fil fil
+ MG fil fil fil
+ R fil rnd rnd
+ MG/+ R fil fil rnd
fil mostly filamentous mitochondria. rnd mostly round, spherical mitochondria.
MG methylglyoxal (0.05 % [v/v]). R rapamycin (1 μM)
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ase (Pc12g04310, EC 1.2.1.2). Two of the identified pep-
tides (#1 and #3) belong to proteins that may play a direct
role in α-oxoaldehyde metabolism while #2 is involved in
homocysteine/methionine metabolism (see Discussion).
Discussion
The results shown here suggest that methylglyoxal re-
duces growth of P. chrysogenum so that the onset of the
stationary phase is delayed. Degradation of peroxisomes
by autophagy in the presence or absence of methyl-
glyoxal was utilized to monitor entry into stationary
phase. It is widely known that methylglyoxal is capable
to readily react with proteins. Are peroxisomal proteins
subjected to glycation? In Arabidopsis thaliana it was
shown that a glyoxalase I homolog, GLX1, is present in
peroxisomes [33]. This result hints that there is a need for
the removal of methylglyoxal at least in plant peroxisomes
(although a GLX2 activity has so far not been demon-
strated in plant peroxisomes). It should be kept in mind
that the glyoxalase system is not the only line of defense
against the toxic effects of α-oxoaldehydes. In addition to
the aldehyde reductases and dehydrogenases described in
the introduction there are also more indirect mechanisms
to prevent the formation of methylglyoxal. In rice it was
shown that an increase in methylglyoxal levels correlated
with an elevated formation of the glycolysis enzyme triose
phosphate isomerase [34]. This reaction results in reduced
formation of DHAP which is giving rise to methylglyoxal
by spontaneous phosphate elimination (see introduction).
So far it is not known if a similar mechanism exists in
other organisms but the possibility is certainly intriguing.
Interestingly, methylglyoxal was found to stimulate
autophagy in bovine aortic endothelial cells [35]. The au-
thors found increased levels of the autophagy marker
proteins Beclin-1 and LC3B-II after methylglyoxal treat-
ment. Furthermore, autophagy flux, as indicated by the
appearance of GFP-LC3 dots, was significantly increased
in the methylglyoxal-treated cells. It is not known
whether other mammalian cell types respond to methyl-
glyoxal in a comparable manner by up-regulating the
molecular autophagy machinery.
No candidates of the molecular machinery regulating
autophagy were identified in the IEF/2D-SDS-PAGE
Fig. 5 Analysis of changes of protein abundance by methylglyoxal treatment in Ws54-1255 by isoelectric focusing/2D-SDS-PAGE/peptide mass
fingerprinting. a Separated proteins of an untreated Ws54-1255 culture grown in YGG medium for 2.5 days at 25 °C visualized by Coomassie Blue
staining. Proteins with different abundance compared to the culture grown in the presence of 0.2 % (v/v) methylglyoxal are marked by black
circles. The identity of selected peptide spots was determined by peptide mass fingerprinting: R-peptide belonging to 60S ribosomal protein L5
(Pc13g11570); 1-peptide belonging to aldo-keto reductase (Pc22g04850); 2-peptide belonging to 5-methyl-tetrahydropteroyl-triglutamate-
homocysteine S-methyltransferase (Pc22g18630); 3-peptide belonging to NAD-dependent formate dehydrogenase (Pc12g04310). b Separated
proteins of a Ws54-1255 culture grown in YGG medium for 2.5 days at 25 °C in the presence of 0.2 % (v/v) methylglyoxal visualized by Coomassie
Blue staining. Regions corresponding to the gel shown in panel a are marked with dotted circles. pI: isoelectric point, MG: methylglyoxal, Mr: relative
molecular mass
Scheckhuber BMC Microbiology  (2015) 15:138 Page 7 of 10experiment. However, peptides from three proteins were
revealed that are present in reduced abundance when
the fungus is grown in medium containing methyl-
glyoxal. Aldo-keto reductase (Pc22g04850) and the
NAD-dependent formate dehydrogenase (Pc12g04310)
have so far not been characterized in detail in P. chryso-
genum. It is certainly possible that both proteins are
involved in methylglyoxal metabolism/detoxification. NAD-
dependent formate dehydrogenase from the methylo-
trophic yeast Candida boidinii was shown to accept
methylglyoxal as a substrate in addition to formaldehyde
[36]. Furthermore, AKR4C14, a rice aldo-keto reductase,
from Thai Jasmine rice is capable to metabolise methyl-
glyoxal in addition to sugars and the aldehydes glutaralde-
hyde and trans-2-hexenal [37]. Therefore Pc22g04850 and
Pc12g04310 might constitute components of a cellular de-
fense system that supports the glyoxalase system in keep-
ing cellular levels of methylglyoxal low. The observation
that these proteins are actually present in decreased abun-
dance when P. chrysogenum is subjected to methylglyoxal
could be explained by a ‘methylglyoxal overload effect’:
the proteins are extensively modified by their reaction
with methylglyoxal so that they become damaged and are
subsequently degraded. Due to the rather high methyl-
glyoxal concentration applied in the experiment the cell
fails to maintain a sufficient supply of these enzymes. This
would make the corresponding genes prime candidates
for their overexpression to further improve the defense
capacity of P. chrysogenum against methylglyoxal and re-
lated α-oxoaldehydes with possibly beneficial effects on
biosynthetic productivity. The protein analysis also identi-
fied 5-methyl-tetrahydropteroyl-triglutamate-homocysteine
S-methyltransferase (Pc22g18630) as a protein which is
present in lowered amounts when methylglyoxal is addedto the growth medium of P. chrysogenum. The enzyme
catalyses the final step in methionine biosynthesis (5-
methyltetrahydropteroyltri-l-glutamate + l-homocysteine ->
tetrahydropteroyltri-l-glutamate + l-methionine) [38]. This
reaction is also important for keeping cellular levels of
homocysteine low. Homocysteine has several deleteri-
ous properties if its cellular levels are elevated, among
them apoptosis induction, increased formation of toxic
reactive oxygen species and interference with cellular
signalling (e. g., due to DNA and RNA methylation, etc.
[39]). Therefore it is possible that cellular stress caused
by increased methylglyoxal levels and a decrease of
5-methyl-tetrahydropteroyl-triglutamate-homocysteine S-
methyltransferase results in the amplification of deleteri-
ous signals which could lead to severe cellular defects. For
example, the observed inhibitory effect of methylglyoxal
on peroxisome degradation could also be based on its in-
direct effects on other metabolic pathways (i. e., homo-
cysteine metabolism).
Conclusions
Methylglyoxal reduces growth of P. chrysogenum culti-
vated on starvation pads so that the onset of stationary
phase (as monitored by the degradation of GFP-SKL la-
belled peroxisomes via autophagy) is delayed. Mitochon-
drial morphology is not compromised by methylglyoxal:
the thread-like morphology is not changed and mitochon-
drial fragmentation is not observed. Three proteins were
identified that are present in lower abundance when methyl-
glyoxal is added to a liquid culture of P. chrysogenum: #1-
Aldo-keto reductase (Pc22g04850); #2–5-methyl-tetrahy-
dropteroyl-triglutamate-homocysteine S-methyltransferase
(Pc22g18630) and #3–NAD-dependent formate dehydro-
genase (Pc12g04310).
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Strains and cultivation conditions
Penicillium chrysogenum Wisconsin(Ws)54–1255 (GFP-
SKL) [40] was used for growth experiments and for the
localisation of green fluorescent protein targeted to per-
oxisomes (GFP-SKL). Stocks grown on rice were stored
at room temperature (RT) in the dark. For initiating
growth from stocks and for the preparation of fresh
stocks 2–3 rice grains were placed on YGG agar (10 g/l
KCl, 20 g/l glucose, 10 g/l yeast nitrogen base, 5 g/l
K2HPO4, 20 g/l yeast extract, 20 g/l agar-agar) and incu-
bated for 4 to 5 days at RT. For cultivation in liquid
medium 15–20 rice grains covered with mycelium were
inoculated in 50 ml YGG medium in a plastic tube for
1 h with occasional mixing. Afterwards the culture (with-
out the rice grains) was transferred to a 250 ml Erlen-
meyer piston. Cultures were incubated for 2 to 3 days at
25 °C at 180 rpm in an Ecotron shaker (Infors GmbH,
Einsbach, Germany). As an autophagy negative control for
the assessment of degradation of peroxisomes the P. chry-
sogenum strain Δatg1 (GFP-SKL) [29] was used in which
all autophagy pathways are blocked. Methylglyoxal (cat.
no. M0252, Sigma-Aldrich, Taufkirchen, Germany) was
added to the media as specified in the corresponding
subsections.
Microscopy
Cultivation of P. chrysogenum for microscopy
For cultivating the Ws54–1255 (GFP-SKL) strain 2–3
rice grains covered with sporulating mycelium (‘green
rice’) were incubated in 500 μl YGG medium in a 1.5 ml
microcentrifuge tube for 1 d at RT after vortexing the
tube for 30 s. From this spore suspension a 1/50 dilu-
tion in sterile tap water was prepared. 5 μl of this di-
luted suspension were pipetted onto an agarose
‘starvation’ pad (1 % (w/v) agarose in sterile tap water
containing no additives (control) or 0.05 % (v/v) methyl-
glyoxal and/or 1 μM rapamycin) that was mounted on
an object carrier with a central cavity [25]. Samples
were incubated at RT for up to 60 h in a wet chamber to
prevent desiccation.
For cultivation of the Δatg1 (GFP-SKL) strain that has
a reduced ability to sporulate [29] 5 μl of an undiluted
spore suspension was pipetted onto an YGG agar
plate and incubated for 5 d at RT. This resulted in the
growth of a mycelium colony. Small pieces of mycelium
were transferred with a sterile toothpick into a 1.5 ml
microcentrifuge tube containing 400 μl sterile tap water
and approx. 100 mg glass beads (0.25 mm-0.5 mm diam-
eter, Carl Roth GmbH, Karlsruhe, Germany). This sus-
pension was vortexed for 2 min. The treatment resulted
in fragmentation of the mycelium. 5 μl of the undiluted
suspension was pipetted onto a starvation pad and incu-
bated as described above.Microscopy analysis
Samples were analysed with an Axio Imager.M2 fluores-
cence microscope equipped with an AxioCam Mrc5
digital camera (Carl Zeiss GmbH, Goettingen, Germany).
Images documenting mycelium growth (bright-field mi-
croscopy) were processed to improve visibility of hyphae
using Photoshop 5.0 (Adobe, San José, CA) as follows: (i)
inverting the picture (pos > neg), (ii) adjustment of bright-
ness/contrast until hyphae were well resolved. The same
settings were applied to all images to allow comparison.
For studying mitochondrial morphology mycelia grown
on starvation pads were carefully overlaid with 10 μM
Mitotracker Green FM (cat. no. M-7514, Fisher Scientific,
Schwerte, Germany) solution for 10 min before analysis
by fluorescence microscopy.Protein extraction
P. chrysogenum cultures were grown for 2.5 d at 25 °C
(180 rpm) in YGG medium (either in the absence or
presence of 0.2 % [v/v] methylglyoxal). After filtration
the mycelium was briefly washed by rinsing it with ster-
ile water. A flat paste of mycelium was wrapped in alu-
minium foil and stored overnight in a freezer at −25 °C.
The next day the frozen mycelium was quickly ground to
a fine powder in a chilled mortar containing cold glass
beads (0.25 mm-0.5 mm diameter, Carl Roth GmbH,
Karlsruhe, Germany) to prevent thawing. The ground
powder was stirred in cold isoelectric focusing buffer (8 M
urea, 2 % [w/v] CHAPS, 0.5 % [v/v] ampholyte solution
pH 3–10 [Fisher Scientific, Schwerte, Germany], 1/1000
protease inhibitor cocktail [cat. no. P8215, Sigma-Aldrich,
Taufkirchen, Germany]) at 4 °C for 1 h. After centrifuga-
tion (10 min, 6000 x g, 4 °C) the supernatant was carefully
removed and an aliquot was analysed for its protein con-
centration. To the rest of the extract bromophenolblue
(final concentration: 0.002 % [w/v]) and 1,4-dithio-DL-
threitol (DTT) (final concentration: 20 mM) were added.
Care was taken that protein extracts were always thawed
on ice and subsequently kept chilled when removed from
the freezer.Protein concentration determination
Preparations were assayed for the protein concentration
by using the ‘Quantipro BCA assay kit’ (Sigma Aldrich,
Taufkirchen, Germany) according to the manufacturer’s
instructions. An aliquot of the extract was diluted 1/10
in isoelectric focusing buffer (without bromophenolblue
and DTT due to the interference of these compounds
with the BCA assay). Samples were incubated for 1 h at
60 °C before absorbance was read at 562 nm. Values
were compared to a reference curve prepared with dif-
ferent dilutions of a bovine serum albumin solution
(supplied with the kit).
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For isoelectric focusing and 2D-SDS-PAGE the ZOOM
system (Fisher Scientific, Schwerte, Germany) was used
according to the manufacturer’s instructions. Isoelectric
focusing buffer (containing 500 μg P. chrysogenum pro-
tein extract) was loaded onto pH 3–10 NL (non-linear)
IEF strips (Fisher Scientific, Schwerte, Germany) and in-
cubated at 4 °C overnight for rehydration of the poly-
acrylamide gel on the strips. IEF was performed with the
following voltage settings: 1 h 100 V, 2 h 200 V, 3 h
500 V. After the run strips were incubated for 15 min in
1 x NuPAGE LDS sample buffer (Fisher Scientific,
Schwerte, Germany) containing 1/10 NuPAGE sample
reducing agent (Fisher Scientific, Schwerte, Germany)
on a shaker at RT. A similar incubation step for 15 min
in 1 x NuPAGE LDS sample buffer containing 125 mM
iodoacetamide followed. Strips were then slid onto ZOOM
gels (4–12 % polyacrylamide gradient gels, Fisher Scien-
tific, Schwerte, Germany) and immobilised with a pre-
warmed solution containing 0.5 % (w/v) agarose in 1 x
NuPAGE MES running buffer (Fisher Scientific, Schwerte,
Germany). 2D-SDS-PAGE was performed for 45 min at
200 V in 1 x NuPAGE MES running buffer.
Staining and documentation of polyacrylamide gels
For the detection of separated proteins in polyacrylamide
gels the ‘Colloidal Blue staining kit’ (Fisher Scientific,
Schwerte, Germany) was used according to the manufac-
turer’s instructions with the following alterations: gels
were incubated overnight in staining solution and de-
stained in pure water (changed every two hours) for at
least 6 h. For documentation purposes gels were placed on
an illumination box (LP200, Doerr, Neu-Ulm, Germany)
equipped with a red light filter and photographed using a
digital camera.
Protein identification
Proteins spots of interest were punched out from stained
SDS-PAGE gels by using cut pipette tips and analysed by
mass spectrometry (MALDI-TOF peptide mass finger-
printing) by Alphalyse A/S, Odense, Denmark. For pro-
tein identification the NCBInr database was accessed
using Mascot version 2.4. Peptide ions were considered
to be positively identified when their Mascot score was
above the 95 % confidence level (i. e., > = 90 for the
NCBInr database).
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